CHRW vs RXO: Which Is the Better Buy in 2026?

Last updated September 2026

Short answer

CHRW is the larger of the two ($17.28B market cap): the incumbent the market prices for continued execution (19.72x forward earnings, beta 0.95). RXO is the smaller challenger ($3.32B), actually pricier on forward earnings (32.94x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

CHRW vs RXO: the tie-breaker metrics

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricCHRWRXOWhat it tells you
Market cap$17.28B$3.32BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E19.7232.94Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta0.951.99Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range28% of range50% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book10.642.20How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: CHRW is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how CHRW and RXO affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CHRW and RXO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CHRW and RXO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does C.H. Robinson Worldwide (CHRW) do?

C.H. Robinson Worldwide is one of the world's largest logistics platforms, operating an asset-light model: it owns very few trucks or ships and instead brokers capacity, matching shippers who need goods moved with the carriers that move them. Its two core engines are North American Surface Transportation (NAST, roughly two-thirds of net revenue, spanning truckload and less-than-truckload brokerage) and Global Forwarding (ocean, air, and customs). The company earns a spread between what shippers pay and what carriers charge, so its profitability tracks freight-market pricing and volume cycles more than gross revenue, which simply passes through freight costs.

Full CHRW guide

What does RXO (RXO) do?

RXO, Inc. was created in November 2022 when XPO spun off its asset-light North American brokered transportation business. The company does not own tractors or trailers. It sells capacity to shippers, buys it from independent carriers, and keeps the spread, which is why revenue is large (~$5.7 billion trailing twelve months) and margins are thin. Truck brokerage is roughly 74% of revenue, with two complementary businesses making up the rest: Last Mile (~18%), which delivers heavy goods like appliances and furniture into homes, and Managed Transportation (~8%), which runs outsourced freight departments for large shippers under multi-year contracts. In September 2024 RXO paid about $1.025 billion for Coyote Logistics from UPS, roughly doubling brokerage volume and moving RXO into the top three North American truck brokers behind C.H. Robinson and Total Quality Logistics. Management has said Coyote synergies run to at least $50 million.

Full RXO guide

CHRW vs RXO: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • CHRW drivers: Margin expansion through automation and cost discipline; Scale and network advantage as the #1 broker.
  • RXO drivers: Truckload capacity leaving the market; Operating leverage on a fixed cost base.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: CHRW operates in an intensely competitive, low-margin industry where it faces asset-based carriers (J.B. For RXO, the largest near-term risk is legal rather than cyclical.

CHRW or RXO: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CHRW if you believe its drivers more; RXO if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CHRW and RXO guides.

CHRW vs RXO: the full fundamentals

CHRW. CHRW trades at a premium mid-30s P/E, a multiple that reflects the market crediting its recent margin turnaround and pricing in an eventual freight-cycle recovery rather than current revenue growth (2025 revenue fell about 8 percent as freight costs passed through lower). Q1 2026 continued the pattern: revenue was roughly flat near $4.0 billion while EPS grew about 15 percent year over year to $1.35. The dividend yields around 1.5 percent with a multi-year record of increases.

RXO. Price-to-earnings does not apply while the company is loss-making, so RXO is usually valued on EV to a normalized EBITDA figure, and the gap between trough EBITDA (roughly $120 million trailing) and what management thinks a recovered cycle looks like is the entire argument. The stock traded between ~$10 and ~$30 over the past year and roughly doubled in 2026 before falling back on the broker-liability news, which tells you the market is repricing the cycle assumption rather than the current results. February 2026 refinancing pushed the senior notes to May 2031 at 6.375% from 7.500%, upsized to $400 million, leaving ~$386 million of available liquidity.

Headline figures (approximate, July 2026): CHRW shows revenue (2025 / ttm) ~$16.2B, net income (2025) ~$587M, diluted eps (2025) ~$4.83, market cap ~$20B; RXO shows revenue (ttm) ~$5.7B, net income (ttm) ~-$105M (~-$0.62 per share), adjusted ebitda (q1 2026) ~$6M on ~$1.43B revenue, market cap ~$3.6B (~$22 per share).

The bottom line: CHRW vs RXO

CHRW and RXO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CHRW and RXO exposure against your real portfolio. It is not an investment adviser.

Wondering how CHRW or RXO fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in C.H. Robinson Worldwide with AI

Connect the broker you already use and ask Walnut's AI how CHRW fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between CHRW and RXO?

+

C.H. RXO, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is CHRW or RXO the better stock?

+

Neither is universally better. CHRW is the larger incumbent; RXO is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, CHRW or RXO?

+

On forward P/E (as of September 2026), CHRW trades at 19.72x and RXO at 32.94x, so CHRW is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both CHRW and RXO?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of CHRW vs RXO?

+

CHRW: CHRW operates in an intensely competitive, low-margin industry where it faces asset-based carriers (J.B. Hunt, Landstar), scaled brokers (RXO, XPO), and well-funded digital entrants (Uber Freight, Amazon Freight) all pressuring the broker spread. Revenue and profit are highly cyclical and sensitive to freight rates, shipping volumes, and global trade flows, so a prolonged freight recession or tariff-driven trade disruption can compress both. Global Forwarding is exposed to volatile ocean and air pricing, which fell sharply in recent periods. The stock trades at an elevated earnings multiple (mid-30s P/E), leaving limited room for execution missteps. And the automation thesis, while promising, is not guaranteed to keep expanding margins if competition commoditizes the technology. RXO: The largest near-term risk is legal rather than cyclical. On 14 May 2026 the Supreme Court ruled unanimously in Montgomery v. Caribe Transport II that state negligent-hiring claims against freight brokers are not preempted by federal law, removing a defense the industry had relied on for years, and a jury subsequently returned a roughly $604 million verdict involving C.H. Robinson. TD Cowen cut RXO to Sell in late July 2026 on that exposure, citing its long-haul mix and balance sheet, while other analysts stayed constructive, so the range of views is unusually wide. Beyond that, the business is a spread business: if capacity comes back before contract rates reset higher, the margin recovery stalls, and RXO has posted a trailing net loss of about $105 million with net leverage near 3.7 times adjusted EBITDA, which is high for a cyclical trough. Last Mile stops were down 8% year over year, so the consumer-facing piece is not offsetting brokerage weakness.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CHRW or RXO; figures are approximate and dated (as of September 2026). Verify current data before investing.